211 related articles for article (PubMed ID: 31734667)
1. The Possibility of Urinary Liver-Type Fatty Acid-Binding Protein as a Biomarker of Renal Hypoxia in Spontaneously Diabetic Torii Fatty Rats.
Tanabe J; Ogura Y; Nakabayashi M; Nagai Y; Watanabe S; Sugaya T; Ohata K; Ichikawa D; Inoue K; Hoshino S; Kimura K; Shibagaki Y; Ono Y; Kamijo-Ikemori A
Kidney Blood Press Res; 2019; 44(6):1476-1492. PubMed ID: 31734667
[TBL] [Abstract][Full Text] [Related]
2. Relationship between Urinary Liver-Type Fatty Acid-Binding Protein (L-FABP) and Sarcopenia in Spontaneously Diabetic Torii Fatty Rats.
Tanabe J; Ogura Y; Kosaki K; Nagai Y; Sugaya T; Ohata K; Watanabe S; Ichikawa D; Inoue K; Hoshino S; Kimura K; Maeda S; Shibagaki Y; Kamijo-Ikemori A
J Diabetes Res; 2020; 2020():7614035. PubMed ID: 32405506
[TBL] [Abstract][Full Text] [Related]
3. Renoprotective effect of GLP-1 receptor agonist, liraglutide, in early-phase diabetic kidney disease in spontaneously diabetic Torii fatty rats.
Yamada S; Tanabe J; Ogura Y; Nagai Y; Sugaya T; Ohata K; Natsuki Y; Ichikawa D; Watanabe S; Inoue K; Hoshino S; Kimura K; Shibagaki Y; Kamijo-Ikemori A
Clin Exp Nephrol; 2021 Apr; 25(4):365-375. PubMed ID: 33409761
[TBL] [Abstract][Full Text] [Related]
4. Effects of excessive sodium chloride loading in the spontaneously diabetic torii (SDT) fatty rats, a preclinical model of type 2 diabetes mellitus.
Teoh SH; Miyajima K; Shinozaki Y; Shinohara M; Ohata K; Briand F; Morimoto R; Nakamura Y; Uno K; Kemuriyama N; Nakae D; Ohta T; Maekawa T
J Toxicol Sci; 2021; 46(12):589-599. PubMed ID: 34853244
[TBL] [Abstract][Full Text] [Related]
5. Endurance Exercise Training-Attenuated Diabetic Kidney Disease with Muscle Weakness in Spontaneously Diabetic Torii Fatty Rats.
Kotake H; Yamada S; Ogura Y; Watanabe S; Inoue K; Ichikawa D; Sugaya T; Ohata K; Natsuki Y; Hoshino S; Watanabe M; Kimura K; Shibagaki Y; Kamijo-Ikemori A
Kidney Blood Press Res; 2022; 47(3):203-218. PubMed ID: 34923497
[TBL] [Abstract][Full Text] [Related]
6. Effects of Tangshen Formula on urinary and plasma liver-type fatty acid binding protein levels in patients with type 2 diabetic kidney disease: post-hoc findings from a multi-center, randomized, double-blind, placebo-controlled trial investigating the efficacy and safety of Tangshen Formula in patients with type 2 diabetic kidney disease.
Yang X; Zhang B; Lu X; Yan M; Wen Y; Zhao T; Li P
BMC Complement Altern Med; 2016 Jul; 16():246. PubMed ID: 27460780
[TBL] [Abstract][Full Text] [Related]
7. Urinary Level of Liver-Type Fatty Acid Binding Protein Reflects the Degree of Tubulointerstitial Damage in Polycystic Kidney Disease.
Watanabe S; Ichikawa D; Sugaya T; Ohata K; Inoue K; Hoshino S; Kimura K; Shibagaki Y; Kamijo-Ikemori A
Kidney Blood Press Res; 2018; 43(6):1716-1729. PubMed ID: 30472704
[TBL] [Abstract][Full Text] [Related]
8. Urinary L-FABP and anaemia: distinct roles of urinary markers in type 2 diabetes.
von Eynatten M; Baumann M; Heemann U; Zdunek D; Hess G; Nawroth PP; Bierhaus A; Humpert PM
Eur J Clin Invest; 2010 Feb; 40(2):95-102. PubMed ID: 19912308
[TBL] [Abstract][Full Text] [Related]
9. Effect of pitavastatin on urinary liver-type fatty acid-binding protein levels in patients with early diabetic nephropathy.
Nakamura T; Sugaya T; Kawagoe Y; Ueda Y; Osada S; Koide H
Diabetes Care; 2005 Nov; 28(11):2728-32. PubMed ID: 16249547
[TBL] [Abstract][Full Text] [Related]
10. Female spontaneously diabetic Torii fatty rats develop nonalcoholic steatohepatitis-like hepatic lesions.
Ishii Y; Motohashi Y; Muramatsu M; Katsuda Y; Miyajima K; Sasase T; Yamada T; Matsui T; Kume S; Ohta T
World J Gastroenterol; 2015 Aug; 21(30):9067-78. PubMed ID: 26290633
[TBL] [Abstract][Full Text] [Related]
11. Nonalbuminuric proteinuria as a biomarker for tubular damage in early development of nephropathy with type 2 diabetic patients.
Kim SS; Song SH; Kim IJ; Kim WJ; Jeon YK; Kim BH; Kwak IS; Lee EK; Kim YK
Diabetes Metab Res Rev; 2014 Nov; 30(8):736-41. PubMed ID: 24687388
[TBL] [Abstract][Full Text] [Related]
12. Level of urinary liver-type fatty acid-binding protein is associated with cardiac markers and electrocardiographic abnormalities in type-2 diabetes with chronic kidney disease stage G1 and G2.
Maeda Y; Suzuki A; Ishii J; Sekiguchi-Ueda S; Shibata M; Yoshino Y; Asano S; Hayakawa N; Nakamura K; Akiyama Y; Kitagawa F; Sakuishi T; Fujita T; Hashimoto S; Ozaki Y; Itoh M
Heart Vessels; 2015 May; 30(3):362-8. PubMed ID: 24626813
[TBL] [Abstract][Full Text] [Related]
13. Urinary liver type fatty acid binding protein in diabetic nephropathy.
Kamijo-Ikemori A; Sugaya T; Ichikawa D; Hoshino S; Matsui K; Yokoyama T; Yasuda T; Hirata K; Kimura K
Clin Chim Acta; 2013 Sep; 424():104-8. PubMed ID: 23727660
[TBL] [Abstract][Full Text] [Related]
14. Contribution of hyperglycemia on diabetic complications in obese type 2 diabetic SDT fatty rats: effects of SGLT inhibitor phlorizin.
Katsuda Y; Sasase T; Tadaki H; Mera Y; Motohashi Y; Kemmochi Y; Toyoda K; Kakimoto K; Kume S; Ohta T
Exp Anim; 2015; 64(2):161-9. PubMed ID: 25736710
[TBL] [Abstract][Full Text] [Related]
15. Association of urinary liver-type fatty acid-binding protein with renal functions and antihyperglycemic drug use in type 2 diabetic nephropathy patients.
Hirowatari K; Kawano N
Int Urol Nephrol; 2023 Aug; 55(8):2111-2118. PubMed ID: 36840803
[TBL] [Abstract][Full Text] [Related]
16. Glucagon-like peptide-1 receptor agonist, liraglutide, attenuated retinal thickening in spontaneously diabetic Torii fatty rats.
Inoue K; Yamada S; Hoshino S; Watanabe M; Kimura K; Kamijo-Ikemori A
BMC Ophthalmol; 2022 May; 22(1):206. PubMed ID: 35524186
[TBL] [Abstract][Full Text] [Related]
17. Glomerular hyperfiltration with hyperglycemia in the spontaneously diabetic Torii (SDT) fatty rat, an obese type 2 diabetic model.
Sano R; Ishii Y; Yamanaka M; Yasui Y; Kemmochi Y; Kuroki F; Sugimoto M; Fukuda S; Sasase T; Miyajima K; Nakae D; Ohta T
Physiol Res; 2021 Mar; 70(1):45-54. PubMed ID: 33453716
[TBL] [Abstract][Full Text] [Related]
18. Diabetes-associated complications in Spontaneously Diabetic Torii fatty rats.
Matsui K; Ohta T; Oda T; Sasase T; Ueda N; Miyajima K; Masuyama T; Shinohara M; Matsushita M
Exp Anim; 2008 Apr; 57(2):111-21. PubMed ID: 18421173
[TBL] [Abstract][Full Text] [Related]
19. Predictive effects of urinary liver-type fatty acid-binding protein for deteriorating renal function and incidence of cardiovascular disease in type 2 diabetic patients without advanced nephropathy.
Araki S; Haneda M; Koya D; Sugaya T; Isshiki K; Kume S; Kashiwagi A; Uzu T; Maegawa H
Diabetes Care; 2013 May; 36(5):1248-53. PubMed ID: 23223350
[TBL] [Abstract][Full Text] [Related]
20. [L-type fatty acid binding protein (L-FABP) and kidney disease].
Kamijo-Ikemori A; Sugaya T; Kimura K
Rinsho Byori; 2014 Feb; 62(2):163-70. PubMed ID: 24800492
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
